Themis Medicare Ltd.
| BSE: 530199 | Sector: Health care |
| NSE: THEMISMED | ISIN Code: INE083B01016 |
| BSE 13:40 | 08 Mar | 312.15 |
1.10 (0.35%) |
OPEN
315.30 |
HIGH
315.30 |
LOW
312.15 |
| NSE 13:29 | 08 Mar | 317.55 |
6.45 (2.07%) |
OPEN
313.25 |
HIGH
317.95 |
LOW
311.35 |
| OPEN | 315.30 |
| PREVIOUS CLOSE | 311.05 |
| VOLUME | 11 |
| 52-Week high | 424.00 |
| 52-Week low | 232.00 |
| P/E | 11.47 |
| Mkt Cap.(Rs cr) | 287 |
| Buy Price | 315.45 |
| Buy Qty | 16.00 |
| Sell Price | 317.85 |
| Sell Qty | 2.00 |
Themis Medicare Ltd. (THEMISMED) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 616.40 | 5.45 | 0.89 | 3211.14 |
| Dr Reddy's Labs | 4495.00 | 5.60 | 0.12 | 2937.70 |
| Cipla | 812.90 | 7.45 | 0.92 | 2318.17 |
| Aurobindo Pharma | 867.95 | 5.35 | 0.62 | 1872.74 |
| Cadila Health. | 448.30 | 6.10 | 1.38 | 1412.90 |
| Divi's Lab. | 3520.00 | 24.15 | 0.69 | 1372.71 |
| Glenmark Pharma. | 487.45 | 19.55 | 4.18 | 1354.55 |
| Alkem Lab | 2780.00 | -0.80 | -0.03 | 1264.42 |
| Alembic Pharma | 917.55 | 0.70 | 0.08 | 969.40 |
| Torrent Pharma. | 2489.35 | 5.95 | 0.24 | 938.51 |
| Gland Pharma | 2568.90 | 18.00 | 0.71 | 772.86 |
| Lupin | 1051.40 | 19.45 | 1.88 | 727.55 |
| Ipca Labs. | 1917.55 | -7.50 | -0.39 | 652.46 |
| Abbott India | 14743.75 | -15.15 | -0.10 | 592.93 |
| Fortis Health. | 178.85 | 1.25 | 0.70 | 513.33 |
| Pfizer | 4715.55 | 82.85 | 1.79 | 509.13 |
| Natco Pharma | 861.05 | 28.30 | 3.40 | 474.50 |
| Apollo Hospitals | 2878.90 | -2.85 | -0.10 | 470.30 |
| Granules India | 347.50 | -1.25 | -0.36 | 444.07 |
| Ajanta Pharma | 1758.55 | 7.10 | 0.41 | 441.13 |
Quick Links for Themis Medicare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
